09 Sep Desert Spine & Sports Physicians to Lead Pivotal Phase III Clinical Trial of Mesoblast’s REXLEMESTROCEL-L for Chronic Low Back Pain
Scottsdale, AZ – Sept 8, 2025 – Desert Spine & Sports Physicians (DSSP) announced today its critical role as a lead clinical partner in a groundbreaking Phase III trial of REXLEMESTROCEL-L, Mesoblast’s investigational regenerative therapy for chronic low back pain caused by degenerative disc disease...